Sandy Douglas, from Oxford University, says updated vaccine could ‘respond to any new variant more rapidly’
Oxford and AstraZeneca have taken “preliminary steps” to produce an updated version of their coronavirus vaccine to specifically target the Omicron variant, a scientist at the university has said.
Sandy Douglas, a research group leader at Oxford, told the Financial Times that an updated vaccine could be used to “respond to any new variant more rapidly” than previously believed.
